A01K 2207/05
Animals modified by non-integrating nucleic acids
Official title: Animals modified by non-integrating nucleic acids, e.g. antisense, RNAi, morpholino, episomal vector, for non-therapeutic purpose
A01K2207/05 (Animals modified by non-integrating nucleic acids) appears on 136 US grants and 273 published applications in this corpus.
Search patents in A01K- Granted patents
- 136
- Published applications
- 273
- Assignees
- 154
- Inventors
- 497
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 2 |
| 2004 | 1 | 2 |
| 2005 | 0 | 2 |
| 2006 | 0 | 0 |
| 2007 | 0 | 5 |
| 2008 | 1 | 6 |
| 2009 | 0 | 13 |
| 2010 | 6 | 11 |
| 2011 | 3 | 21 |
| 2012 | 2 | 20 |
| 2013 | 10 | 12 |
| 2014 | 10 | 16 |
| 2015 | 11 | 13 |
| 2016 | 9 | 21 |
| 2017 | 13 | 13 |
| 2018 | 9 | 17 |
| 2019 | 8 | 10 |
| 2020 | 10 | 18 |
| 2021 | 10 | 18 |
| 2022 | 4 | 12 |
| 2023 | 4 | 7 |
| 2024 | 12 | 11 |
| 2025 | 9 | 15 |
| 2026 | 3 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for generating physiological X chromosome inactivation26 May 2026US 12,637,697 B2Children's Medical Center Corporation
- Methods for treating hepatitis B infection3 Mar 2026US 12,564,601 B2Dicerna Pharmaceuticals, Inc.
- Compositions and methods for determining genetic polymorphisms in the TMEM216 gene24 Feb 2026US 12,559,798 B2The Regents of the University of California
- Compositions and methods of use thereof for treatment of metabolic diseases and related disorders30 Dec 2025US 12,508,306 B2Washington University
- Ionizable lipids for nucleic acid delivery23 Dec 2025US 12,503,432 B2Global Life Sciences Solutions Canada ULC
- Compositions and methods for determining genetic polymorphisms in the tmem216 gene24 Sep 2026US 2026/0286437 A1The Regents of the University of California
- Compositions and methods for generating porcine ovarian tumor model6 Aug 2026US 2026/0223823 A1Georgia Tech Research Corporation
- Methods for treating monge's disease9 Jul 2026US 2026/0193659 A1The Regents of the University of California
- Methods for treating hepatitis b infection4 Jun 2026US 2026/0151421 A1Dicerna Pharmaceuticals, Inc.
- Ionizable lipids for nucleic acid delivery19 Mar 2026US 2026/0078085 A1Global Life Sciences Solutions Canada ULC
Most cited
By later US patents
- Isolation of novel AAV'S and uses thereof107US 9,217,155 B2University of Massachusetts · 2015
- Light-sensitive ion-passing molecules75US 9,359,449 B2The Board of Trustees of the Leland Stanford Junior University · 2016
- Light-sensitive ion-passing molecules67US 9,079,940 B2The Board of Trustees of the Leland Stanford Junior University · 2015
- Light-sensitive ion-passing molecules63US 9,249,234 B2The Board of Trustees of the Leland Stanford Junior University · 2016
- Isolation of novel AAV's and uses thereof63US 9,596,835 B2University of Massachusetts · 2017